Lyell Immunopharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MWG MANAGEMENT LTD. | 11/08/2024 | 20.16 M | $27.82 M | 0.00% | 7.87% |
| ORLAND PROPERTIES LTD | 11/08/2024 | 15.09 M | $20.83 M | 0.00% | 5.89% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 13.75 M | $18.97 M | 100.00% | 5.36% |
| VANGUARD GROUP INC | 11/13/2024 | 10.07 M | $13.90 M | -24.83% | 3.93% |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 11/14/2024 | 8.33 M | $11.49 M | 0.00% | 3.25% |
| WUXI APPTEC CO., LTD. | 11/08/2024 | 7.39 M | $10.20 M | -3.79% | 2.88% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 7.35 M | $10.15 M | -6.61% | 2.87% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 6.09 M | $8.40 M | -4.98% | 2.37% |
| ALPHABET INC. | 11/08/2024 | 5.87 M | $8.09 M | 0.00% | 2.29% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 4.02 M | $5.55 M | 0.20% | 1.57% |
| STATE STREET CORP | 11/14/2024 | 3.89 M | $5.37 M | 1.87% | 1.52% |
| SC CHINA HOLDING LTD | 11/13/2024 | 3.05 M | $3.41 M | 0.00% | 1.19% |
| MIC CAPITAL MANAGEMENT UK LLP | 11/14/2024 | 1.74 M | $2.40 M | 0.00% | 0.68% |
| MORGAN STANLEY | 11/14/2024 | 1.73 M | $2.38 M | 283.33% | 0.67% |
| OPALEYE MANAGEMENT INC. | 11/14/2024 | 1.40 M | $1.93 M | -16.47% | 0.54% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 1.20 M | $1.65 M | 21.54% | 0.47% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.15 M | $1.58 M | -11.58% | 0.45% |
| FMR LLC | 11/13/2024 | 1.02 M | $1.41 M | -62.52% | 0.40% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 1.00 M | $1.52 M | 0.00% | 0.39% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 856,487 | $1.18 M | 1.57% | 0.33% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 832,323 | $1.15 M | 138.48% | 0.32% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 710,067 | $979,892 | -12.29% | 0.28% |
| CANADA PENSION PLAN INVESTMENT BOARD | 11/14/2024 | 588,235 | $811,764 | 0.00% | 0.23% |
| HRT FINANCIAL LP | 11/12/2024 | 569,016 | $785,000 | 100.00% | 0.22% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 552,556 | $762,527 | -0.11% | 0.22% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 526,066 | $725,971 | 0.00% | 0.21% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 525,782 | $725,579 | -21.75% | 0.21% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 472,626 | $652,224 | 17.91% | 0.18% |
| INVESCO LTD. | 11/12/2024 | 405,949 | $560,210 | -0.23% | 0.16% |
| CLARIUS GROUP, LLC | 10/09/2024 | 399,168 | $550,852 | 0.00% | 0.16% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 354,815 | $490,000 | 1,285.45% | 0.14% |
| JANE STREET GROUP, LLC | 11/15/2024 | 287,717 | $397,049 | 63.66% | 0.11% |
| RHUMBLINE ADVISERS | 11/12/2024 | 273,771 | $377,792 | 5.00% | 0.11% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 271,996 | $375,354 | -12.94% | 0.11% |
| SWISS NATIONAL BANK | 11/07/2024 | 247,400 | $341,412 | 0.00% | 0.10% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 241,836 | $333,734 | -39.27% | 0.09% |
| BARCLAYS PLC | 11/19/2024 | 240,615 | $332,000 | 312.72% | 0.09% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 220,790 | $304,690 | 0.00% | 0.09% |
| ENTRYPOINT CAPITAL, LLC | 11/13/2024 | 207,996 | $287,034 | 100.00% | 0.08% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 197,400 | $272,412 | 29.61% | 0.08% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 168,756 | $232,883 | 18.12% | 0.07% |
| BBR PARTNERS, LLC | 11/13/2024 | 164,041 | $226,377 | 0.00% | 0.06% |
| BAILLIE GIFFORD & CO | 11/05/2024 | 141,949 | $195,889 | -72.70% | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 139,880 | $193,034 | 0.00% | 0.05% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 135,500 | $186,990 | 100.00% | 0.05% |
| EXCHANGE TRADED CONCEPTS, LLC | 10/10/2024 | 135,050 | $186,369 | 37.34% | 0.05% |
| SHELL ASSET MANAGEMENT CO | 11/07/2024 | 127,985 | $177,000 | 100.00% | 0.05% |
| LEGAL & GENERAL GROUP PLC | 11/14/2024 | 127,617 | $175,658 | 0.00% | 0.05% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 125,700 | $173,466 | -12.28% | 0.05% |
| TUDOR INVESTMENT CORP ET AL | 11/14/2024 | 124,320 | $171,562 | 0.00% | 0.05% |
Lyell Immunopharma, Inc.institutional Ownership - FAQ's
During the previous two years, 140 institutional investors and hedge funds held shares of Lyell Immunopharma, Inc.. The most heavily invested institutionals were:
MWG Management Ltd.: 20.16 M
Orland Properties Ltd: 15.09 M
BlackRock Funding, Inc. /DE: 13.75 M
VANGUARD GROUP INC: 10.07 M
Foresite Capital Management IV, LLC: 8.33 M
WuXi AppTec Co., Ltd.: 7.39 M
50.11% of Lyell Immunopharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 156.74 M shares in the last 24 months. This purchase volume represents approximately $101.88 M in transactions.